Literature DB >> 19703426

Altered gene expression in neural crest cells exposed to ethanol in vitro.

Parri Wentzel1, Ulf J Eriksson.   

Abstract

AIM: to characterize and compare ethanol-induced changes of gene expression in cells from the cranial (cNCC) and trunk (tNCC) portion of the neural crest cell (NCC) population of day-10 rat embryos.
BACKGROUND: previous work has suggested that ethanol-induced embryonic maldevelopment is associated with oxidative stress, and, in particular, that ethanol-induced anomalies of the facial skeleton and heart are associated with disturbed development of the cNCC. We studied alterations of mRNA levels of genes involved in apoptosis, oxidative defense, cellular metabolism, NCC development or inflammation in cNCC and tNCC from rat embryos exposed to ethanol in vitro. We specifically evaluated expression differences between cNCC and tNCC genes, possibly reflecting the different teratological susceptibilities of the two cell populations.
METHODS: neural tube explants from rat embryos were divided in cranial and trunk portions and used for NCC isolation in vitro on gestational day 10. The migrating cells from the cranial or trunk explants of the neural tube were subsequently exposed to 0 or 88 mmol/l ethanol concentration with or without addition of 0.5 mM N-acetylcysteine (NAC) for 48 h, harvested, and prepared for gene expression measurement by RT-PCR or immunostaining with either distal-less (DLX) or AP 2-alpha antibodies.
RESULTS: evaluation of the immunostained slides showed that approximately 75% of the cNCC and tNCC preparations were of neural crest origin. Exposure to 88 mM ethanol increased the Bax/Bcl-2 ratio in the NCC, and NAC addition diminished this increase. Both cNCC and tNCC upregulated MnSOD and Gpx-1 in response to ethanol, whereas tNCC increased CuZnSOD and EC-SOD after ethanol exposure (cNCC unchanged). Expression of glyceraldehyde-3-phosphate dehydrogenase was downregulated by ethanol in cNCC only. In addition, ethanol exposure caused increased mRNA levels of Pax-3, p53, Vegf-A and decreased expression of Pax-6, Nfe2 in both cNCC and tNCC. Ethanol increased Shh and Bmp-4 and decreased Parp only in cNCC (tNCC unchanged), whereas ethanol exposure increased T box-2 and decreased Gdnf and Ret only in tNCC (cNCC unchanged). In addition, ethanol exposure almost abolished expression of Hox a(1), a(4) and a(5), and left Hox a(2) unchanged in cNCC, whereas all four of these Hox genes were upregulated in tNCC.
CONCLUSIONS: ethanol causes a shift towards apoptosis in both cNCC and tNCC, a shift, which is diminished by NAC treatment. Oxidative defense genes, and genes involved in neural crest cell development are affected differently in cNCC compared to tNCC upon ethanol exposure. Moreover, ethanol downregulates cNCC Hox genes, whereas tNCC Hox genes are upregulated. These patterns of ethanol-altered gene expression may be of etiological importance for NCC-associated maldevelopment in ethanol-exposed pregnancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703426     DOI: 10.1016/j.brainres.2009.08.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  The neural crest in cardiac congenital anomalies.

Authors:  Anna Keyte; Mary Redmond Hutson
Journal:  Differentiation       Date:  2012-05-15       Impact factor: 3.880

2.  Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts.

Authors:  Tania A Desrosiers; Christina C Lawson; Robert E Meyer; David B Richardson; Julie L Daniels; Martha A Waters; Edwin van Wijngaarden; Peter H Langlois; Paul A Romitti; Adolfo Correa; A Olshan
Journal:  Occup Environ Med       Date:  2012-03-23       Impact factor: 4.402

3.  Fetal alcohol syndrome, chemo-biology and OMICS: ethanol effects on vitamin metabolism during neurodevelopment as measured by systems biology analysis.

Authors:  Bruno César Feltes; Joice de Faria Poloni; Itamar José Guimarães Nunes; Diego Bonatto
Journal:  OMICS       Date:  2014-05-09

Review 4.  Neural crest development in fetal alcohol syndrome.

Authors:  Susan M Smith; Ana Garic; George R Flentke; Mark E Berres
Journal:  Birth Defects Res C Embryo Today       Date:  2014-09-15

5.  Genetic dissection of the Canq1 locus governing variation in extent of the collateral circulation.

Authors:  Shiliang Wang; Hua Zhang; Tim Wiltshire; Robert Sealock; James E Faber
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

6.  Dose-dependent alcohol-induced alterations in chromatin structure persist beyond the window of exposure and correlate with fetal alcohol syndrome birth defects.

Authors:  Kylee J Veazey; Scott E Parnell; Rajesh C Miranda; Michael C Golding
Journal:  Epigenetics Chromatin       Date:  2015-09-28       Impact factor: 4.954

7.  Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells.

Authors:  T R Daniels; I I Neacato; J A Rodríguez; H S Pandha; R Morgan; M L Penichet
Journal:  Leukemia       Date:  2010-06-24       Impact factor: 11.528

8.  Association of Parental Environmental Exposures and Supplementation Intake with Risk of Nonsyndromic Orofacial Clefts: A Case-Control Study in Heilongjiang Province, China.

Authors:  Yanru Hao; Subao Tian; Xiaohui Jiao; Na Mi; Bing Zhang; Tao Song; Le An; Xudong Zheng; Deshu Zhuang
Journal:  Nutrients       Date:  2015-08-27       Impact factor: 5.717

Review 9.  Capturing structure and function in an embryonic heart with biophotonic tools.

Authors:  Ganga H Karunamuni; Shi Gu; Matthew R Ford; Lindsy M Peterson; Pei Ma; Yves T Wang; Andrew M Rollins; Michael W Jenkins; Michiko Watanabe
Journal:  Front Physiol       Date:  2014-09-23       Impact factor: 4.566

10.  Novel Ethanol-Sensitive Mutants Identified in an F3 Forward Genetic Screen.

Authors:  Mary E Swartz; Charles Ben Lovely; Neil McCarthy; Tim Kuka; Johann K Eberhart
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.